Detecting Pancreatic Cancer, Glioblastoma, and Alzheimer’s Early | University of Notre Dame @NotreDame
Detecting Pancreatic Cancer, Glioblastoma, and Alzheimer’s Early | University of Notre Dame  @NotreDame
Uploaded November 2026 | Updated November 2026, 3 days ago
University of Notre Dame Professor Hsueh-Chia Chang and his research team have developed a new blood-screening technology designed to detect four devastating illnesses—pancreatic cancer, glioblastoma, colorectal cancer, and Alzheimer’s disease—in their earliest stages.

By identifying these conditions sooner, this diagnostic innovation aims to give patients a better chance at effective treatment and survival.

Learn more about how Notre Dame researchers are working to advance human health and solve pressing global challenges:
Detecting Pancreatic Cancer, Glioblastoma, and Alzheimer’s Early | University of Notre DameCommencement 2025: What Will You Miss Most? (Part 2)Class of 2025 Commencement HighlightsMemorial Mass for Pope Francis at the Basilica of the Sacred HeartIntroducing: Notre Dame CircleHow a business school is helping the clean water crisisNotre Dame Yule LogNotre Dame and the Vatican Launch Global Alliance for Laudato Si2026 Commencement: Notre Dame, Our MotherHow can Catholics support the conclave?How do you measure success?2026 Commencement: Mathematics undergraduate ceremony
University of Notre Dame |

Detecting Pancreatic Cancer, Glioblastoma, and Alzheimer’s Early | University of Notre Dame

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER